These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31479642)

  • 21. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices.
    Shah R; Qayed E
    South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-Hospital Outcomes of Left Ventricular Assist Device Implantation and Concomitant Valvular Surgery.
    Briasoulis A; Yokoyama Y; Kuno T; Ueyama H; Shetty S; Alvarez P; Malik AΗ
    Am J Cardiol; 2020 Oct; 132():87-92. PubMed ID: 32753267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors and Outcomes of Gastrointestinal Bleeding in Left Ventricular Assist Device Recipients.
    Joy PS; Kumar G; Guddati AK; Bhama JK; Cadaret LM
    Am J Cardiol; 2016 Jan; 117(2):240-4. PubMed ID: 26651456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in utilization, mortality, major complications, and cost after total artificial heart implantation in the United States (2009-2015).
    Briasoulis A; Akintoye E; Mohsen A; Inampudi C; Briasouli A; Asleh R; Alvarez P
    Hellenic J Cardiol; 2020; 61(6):407-412. PubMed ID: 30790715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
    Borgi J; Tsiouris A; Hodari A; Cogan CM; Paone G; Morgan JA
    Ann Thorac Surg; 2013 Jan; 95(1):163-9. PubMed ID: 23103012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation.
    Blumer V; Ortiz Bezara M; Kittipibul V; Greene SJ; Fudim M; Hernandez GA; Chaparro S; Joyce E
    J Cardiovasc Transl Res; 2021 Feb; 14(1):120-124. PubMed ID: 32076994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital Complications and Causes of 90-Day Readmissions After Implantation of Left Ventricular Assist Devices.
    Tripathi B; Arora S; Kumar V; Thakur K; Lahewala S; Patel N; Dave M; Shah M; Savani S; Sharma P; Bandyopadhyay D; Shantha GPS; Egbe A; Chatterjee S; Patel NK; Gopalan R; Figueredo VM; Deshmukh A
    Am J Cardiol; 2018 Aug; 122(3):420-430. PubMed ID: 29960661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of LVAD utilization in older adults.
    Gazda AJ; Kwak MJ; Akkanti B; Nathan S; Kumar S; de Armas IS; Baer P; Patel B; Kar B; Gregoric ID
    Heart Lung; 2021; 50(1):75-79. PubMed ID: 32709497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of ventricular arrhythmia after left ventricular assist device implantation: A large single-center observational study.
    Efimova E; Fischer J; Bertagnolli L; Dinov B; Kircher S; Rolf S; Sommer P; Bollmann A; Richter S; Meyer A; Garbade J; Hindricks G; Arya A
    Heart Rhythm; 2017 Dec; 14(12):1812-1819. PubMed ID: 28756099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial disparities in in-hospital outcomes after left ventricular assist device implantation.
    Ueyama H; Malik A; Kuno T; Yokoyama Y; Briasouli A; Shetty S; Briasoulis A
    J Card Surg; 2020 Oct; 35(10):2633-2639. PubMed ID: 32667085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.
    Wang X; Luke AA; Vader JM; Maddox TM; Joynt Maddox KE
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006284. PubMed ID: 32394720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed sternal closure does not reduce complications associated with coagulopathy and right ventricular failure after left ventricular assist device implantation.
    Yanagida R; Rajagopalan N; Davenport DL; Tribble TA; Bradley MA; Hoopes CW
    J Artif Organs; 2018 Mar; 21(1):46-51. PubMed ID: 28948385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creation and Validation of a Novel Sex-Specific Mortality Risk Score in LVAD Recipients.
    Nayak A; Hu Y; Ko YA; Steinberg R; Das S; Mehta A; Liu C; Pennington J; Xie R; Kirklin JK; Kormos RL; Cowger J; Simon MA; Morris AA
    J Am Heart Assoc; 2021 Apr; 10(7):e020019. PubMed ID: 33764158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation.
    Song HK; Gelow JM; Mudd J; Chien C; Tibayan FA; Hollifield K; Naftel D; Kirklin J
    Ann Thorac Surg; 2016 Jun; 101(6):2168-74. PubMed ID: 27139368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular complications associated with percutaneous left ventricular assist device placement: A 10-year US perspective.
    Patel N; Sharma A; Dalia T; Rali A; Earnest M; Tadros P; Wiley M; Hockstad E; Mehta A; Thors A; Hance K; Gupta K
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):309-316. PubMed ID: 31638737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should women receive left ventricular assist device support?: findings from INTERMACS.
    Hsich EM; Naftel DC; Myers SL; Gorodeski EZ; Grady KL; Schmuhl D; Ulisney KL; Young JB
    Circ Heart Fail; 2012 Mar; 5(2):234-40. PubMed ID: 22260946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.